Lipophilicity, quantified as logP and logD, is a fundamental physicochemical property that critically influences the absorption, distribution, metabolism, and excretion (ADME) of potential drug candidates.
This article provides a comprehensive examination of the critical relationship between lipophilicity and metabolic clearance, a key determinant of drug candidate success.
This article provides a thorough examination of the critical relationship between drug lipophilicity (logP) and the volume of distribution (VDss), a key pharmacokinetic parameter.
Drug-induced hERG channel blockade is a leading cause of costly late-stage drug attrition due to cardiotoxicity.
This article provides a comprehensive analysis of the critical role of lipophilicity in blood-brain barrier (BBB) penetration for central nervous system (CNS) drug development.
This article provides a comprehensive guide for researchers and drug development professionals on the critical balance between lipophilicity and permeability, a key determinant of oral bioavailability.
This article provides a comprehensive analysis of the intricate relationship between lipophilicity and plasma protein binding (PPB), a cornerstone of pharmacokinetic optimization.
This article explores the critical intersection of molecular obesity mechanisms and lipophilicity in modern drug discovery.
This article provides a comprehensive analysis of the critical role lipophilicity plays in the pharmacokinetics of drug candidates, specifically focusing on absorption and distribution.
Lipophilicity, quantified as LogP and LogD, is a fundamental physicochemical property that critically influences the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) of drug candidates.